11/1/23 17:59 | 10/30/23 | IMGN | Immunogen, Inc. | MA | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | M.d | 298 | 14.89 | 0 | 20 | 50 | 60 | D | | | | | | | | | | | | | | |
3/7/22 16:05 | 3/3/22 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | P | 300 | 59.98 | 0 | 5 | 86 | 11 | D | | | | | | | | | | | | | | |
12/28/20 16:23 | 12/24/20 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | M.d | 154 | 28.15 | 0 | 5 | | 4 | D | | | | | | | | | | | | | | |
12/28/20 16:23 | 12/24/20 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | S.d | -682 | 125.00 | 0 | -5 | -60 | 4 | D | | | | | | | | | | | | | | |
12/22/20 16:14 | 12/18/20 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | M.d | 154 | 28.15 | 0 | 5 | | 4 | D | | | | | | | | | | | | | | |
12/22/20 16:14 | 12/18/20 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | S.d | -654 | 120.00 | 0 | -5 | -60 | 4 | D | | | | | | | | | | | | | | |
12/15/20 16:08 | 12/11/20 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | M.d | 154 | 28.15 | 0 | 5 | | 4 | D | | | | | | | | | | | | | | |
12/15/20 16:08 | 12/11/20 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | S.d | -627 | 115.00 | 0 | -5 | -60 | 4 | D | | | | | | | | | | | | | | |
12/3/20 16:10 | 12/1/20 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | M.d | 154 | 28.15 | 0 | 5 | | 4 | D | | | | | | | | | | | | | | |
12/3/20 16:10 | 12/1/20 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | S.d | -600 | 110.00 | 0 | -5 | -60 | 4 | D | | | | | | | | | | | | | | |
10/21/20 16:21 | 10/19/20 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | M.d | 107 | 19.53 | 0 | 5 | | 4 | D | | | | | | | | | | | | | | |
10/21/20 16:21 | 10/19/20 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | S.d | -573 | 105.00 | 0 | -5 | -60 | 4 | D | | | | | | | | | | | | | | |
10/9/20 16:04 | 10/7/20 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | M.d | 107 | 19.53 | 0 | 5 | | 4 | D | | | | | | | | | | | | | | |
10/9/20 16:04 | 10/7/20 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | S.d | -545 | 100.00 | 0 | -5 | -60 | 4 | D | | | | | | | | | | | | | | |
6/23/20 16:11 | 6/19/20 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | M.d | 0 | 0.00 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
12/20/18 17:26 | 12/19/18 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | PA | D | | P | 32 | 3.19 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
11/7/18 09:54 | 11/6/18 | IMGN | Immunogen Inc | MA | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | P | 173 | 5.76 | 0 | 30 | 126 | 54 | D | | | | | | | | | | | | | | |
12/15/16 11:51 | 12/15/16 | IMGN | Immunogen Inc | MA | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | P | 36 | 1.80 | 2 | 20 | 526 | 24 | D | -81 | -86 | -49 | -36 | 8 | -12 | -11 | -3 | -5 | -12 | 44 | 101 | | |
3/7/16 08:03 | 3/4/16 | GLYC | Glycomimetics Inc | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MD | D | | P | 50 | 4.77 | 0 | 10 | 945 | 11 | D | -65 | -37 | -26 | -25 | 3 | 32 | 4 | 15 | 18 | 9 | 18 | 73 | 43 | 24 |
9/19/14 17:56 | 9/19/14 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | EVP,Medi | M.d | 7 | 8.73 | 0 | 1 | | 1 | D | | | | | | | | | | | | | | |
9/19/14 17:56 | 9/19/14 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | EVP,Medi | S.d | -52 | 65.24 | 0 | -1 | -58 | 1 | D | | | | | | | | | | | | | | |
9/18/14 17:21 | 9/16/14 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | EVP,Medi | M.dm | 119 | 8.73 | 0 | 14 | | 1 | D | | | | | | | | | | | | | | |
9/18/14 17:21 | 9/16/14 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | EVP,Medi | S.dm | -883 | 65.03 | 0 | -14 | -96 | 1 | D | | | | | | | | | | | | | | |
6/12/14 17:07 | 6/11/14 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | EVP,Medi | M.d | 166 | 7.66 | 0 | 22 | | 0 | D | | | | | | | | | | | | | | |
6/12/14 17:07 | 6/11/14 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | EVP,Medi | S.d | -1,728 | 80.00 | 0 | -22 | -98 | 0 | D | | | | | | | | | | | | | | |
12/4/13 17:07 | 12/2/13 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | SVP,Medi | M.d | 61 | 8.73 | 0 | 7 | | 0 | D | | | | | | | | | | | | | | |
12/4/13 17:07 | 12/3/13 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | SVP,Medi | S.d | -424 | 60.52 | 0 | -7 | -96 | 0 | D | | | | | | | | | | | | | | |
11/4/13 17:35 | 11/1/13 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | SVP,Medi | M.d | 61 | 8.73 | 0 | 7 | | 0 | D | | | | | | | | | | | | | | |
11/4/13 17:35 | 11/1/13 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | SVP,Medi | S.d | -350 | 49.96 | 0 | -7 | -96 | 0 | D | | | | | | | | | | | | | | |
10/3/13 16:07 | 10/1/13 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | SVP,Medi | M.d | 61 | 8.73 | 0 | 7 | | 0 | D | | | | | | | | | | | | | | |
10/3/13 16:07 | 10/1/13 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | SVP,Medi | S.d | -450 | 64.31 | 0 | -7 | -96 | 0 | D | | | | | | | | | | | | | | |
4/3/13 10:21 | 4/1/13 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | SVP,Medi | M.d | 4 | 0.9500 | 0 | 4 | | 0 | D | | | | | | | | | | | | | | |
4/3/13 10:21 | 4/1/13 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | SVP,Medi | S.d | -240 | 54.31 | 0 | -4 | -100 | 0 | D | | | | | | | | | | | | | | |
3/6/13 06:00 | 3/1/13 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | SVP,Prod | M.d | 4 | 0.9500 | 0 | 4 | | 0 | D | | | | | | | | | | | | | | |
3/6/13 06:00 | 3/1/13 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | SVP,Prod | S.d | -224 | 50.76 | 0 | -4 | -100 | 0 | D | | | | | | | | | | | | | | |
2/5/13 17:35 | 2/1/13 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | SVP,Prod | M.d | 4 | 0.9500 | 0 | 4 | | 0 | D | | | | | | | | | | | | | | |
2/5/13 17:35 | 2/1/13 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | SVP,Prod | S.d | -211 | 47.75 | 0 | -4 | -100 | 0 | D | | | | | | | | | | | | | | |
1/4/13 16:30 | 1/2/13 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | SVP,Prod | M.d | 4 | 0.9500 | 0 | 4 | | 0 | D | | | | | | | | | | | | | | |
1/4/13 16:30 | 1/2/13 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | MA | O | SVP,Prod | S.d | -210 | 47.52 | 0 | -4 | -100 | 0 | D | | | | | | | | | | | | | | |
11/9/12 11:06 | 11/8/12 | IMGN | Immunogen Inc | MA | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | | P | 34 | 11.27 | 8 | 3 | 375 | 4 | D | 39 | -16 | -14 | -13 | -30 | -28 | -3 | -3 | 1 | 0 | 12 | 32 | 50 | 23 |